- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Mantle Cell Lymphoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Mantle Cell Lymphoma Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Mantle Cell Lymphoma Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Acalabrutinib segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Mantle Cell Lymphoma Treatment include Astex Pharmaceuticals, Inc., Bayer AG, Bristol-Myers Squibb Company, Celgene Corporation, and Cellular Biomedicine Group, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Mantle Cell Lymphoma Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Acalabrutinib
JCAR-017
JNJ-64052781
Acalisib
IGN-002
IMGN-529
AFM-11
Others
Market segment by Application, can be divided into
Hospital
Clinic
Others
Market segment by players, this report covers
Astex Pharmaceuticals, Inc.
Bayer AG
Bristol-Myers Squibb Company
Celgene Corporation
Cellular Biomedicine Group, Inc.
Eisai
EpiZyme, Inc.
Fate Therapeutics, Inc.
Genentech, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Hutchison MediPharma Limited
ImmunoGen, Inc.
Immunomedics, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Mantle Cell Lymphoma Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Mantle Cell Lymphoma Treatment, with revenue, gross margin and global market share of Mantle Cell Lymphoma Treatment from 2019 to 2022.
Chapter 3, the Mantle Cell Lymphoma Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Mantle Cell Lymphoma Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Mantle Cell Lymphoma Treatment research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Mantle Cell Lymphoma Treatment
1.2 Classification of Mantle Cell Lymphoma Treatment by Type
1.2.1 Overview: Global Mantle Cell Lymphoma Treatment Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Mantle Cell Lymphoma Treatment Revenue Market Share by Type in 2021
1.2.3 Acalabrutinib
1.2.4 JCAR-017
1.2.5 JNJ-64052781
1.2.6 Acalisib
1.2.7 IGN-002
1.2.8 IMGN-529
1.2.9 AFM-11
1.2.10 Others
1.3 Global Mantle Cell Lymphoma Treatment Market by Application
1.3.1 Overview: Global Mantle Cell Lymphoma Treatment Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Mantle Cell Lymphoma Treatment Market Size & Forecast
1.5 Global Mantle Cell Lymphoma Treatment Market Size and Forecast by Region
1.5.1 Global Mantle Cell Lymphoma Treatment Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Mantle Cell Lymphoma Treatment Market Size by Region, (2017-2022)
1.5.3 North America Mantle Cell Lymphoma Treatment Market Size and Prospect (2017-2028)
1.5.4 Europe Mantle Cell Lymphoma Treatment Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size and Prospect (2017-2028)
1.5.6 South America Mantle Cell Lymphoma Treatment Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Mantle Cell Lymphoma Treatment Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Mantle Cell Lymphoma Treatment Market Drivers
1.6.2 Mantle Cell Lymphoma Treatment Market Restraints
1.6.3 Mantle Cell Lymphoma Treatment Trends Analysis
2 Company Profiles
2.1 Astex Pharmaceuticals, Inc.
2.1.1 Astex Pharmaceuticals, Inc. Details
2.1.2 Astex Pharmaceuticals, Inc. Major Business
2.1.3 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Product and Solutions
2.1.4 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Astex Pharmaceuticals, Inc. Recent Developments and Future Plans
2.2 Bayer AG
2.2.1 Bayer AG Details
2.2.2 Bayer AG Major Business
2.2.3 Bayer AG Mantle Cell Lymphoma Treatment Product and Solutions
2.2.4 Bayer AG Mantle Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Bayer AG Recent Developments and Future Plans
2.3 Bristol-Myers Squibb Company
2.3.1 Bristol-Myers Squibb Company Details
2.3.2 Bristol-Myers Squibb Company Major Business
2.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Product and Solutions
2.3.4 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
2.4 Celgene Corporation
2.4.1 Celgene Corporation Details
2.4.2 Celgene Corporation Major Business
2.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Product and Solutions
2.4.4 Celgene Corporation Mantle Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Celgene Corporation Recent Developments and Future Plans
2.5 Cellular Biomedicine Group, Inc.
2.5.1 Cellular Biomedicine Group, Inc. Details
2.5.2 Cellular Biomedicine Group, Inc. Major Business
2.5.3 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Product and Solutions
2.5.4 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Cellular Biomedicine Group, Inc. Recent Developments and Future Plans
2.6 Eisai
2.6.1 Eisai Details
2.6.2 Eisai Major Business
2.6.3 Eisai Mantle Cell Lymphoma Treatment Product and Solutions
2.6.4 Eisai Mantle Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Eisai Recent Developments and Future Plans
2.7 EpiZyme, Inc.
2.7.1 EpiZyme, Inc. Details
2.7.2 EpiZyme, Inc. Major Business
2.7.3 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Product and Solutions
2.7.4 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 EpiZyme, Inc. Recent Developments and Future Plans
2.8 Fate Therapeutics, Inc.
2.8.1 Fate Therapeutics, Inc. Details
2.8.2 Fate Therapeutics, Inc. Major Business
2.8.3 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Product and Solutions
2.8.4 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Fate Therapeutics, Inc. Recent Developments and Future Plans
2.9 Genentech, Inc.
2.9.1 Genentech, Inc. Details
2.9.2 Genentech, Inc. Major Business
2.9.3 Genentech, Inc. Mantle Cell Lymphoma Treatment Product and Solutions
2.9.4 Genentech, Inc. Mantle Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Genentech, Inc. Recent Developments and Future Plans
2.10 Gilead Sciences, Inc.
2.10.1 Gilead Sciences, Inc. Details
2.10.2 Gilead Sciences, Inc. Major Business
2.10.3 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Product and Solutions
2.10.4 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Gilead Sciences, Inc. Recent Developments and Future Plans
2.11 GlaxoSmithKline Plc
2.11.1 GlaxoSmithKline Plc Details
2.11.2 GlaxoSmithKline Plc Major Business
2.11.3 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Product and Solutions
2.11.4 GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 GlaxoSmithKline Plc Recent Developments and Future Plans
2.12 Hutchison MediPharma Limited
2.12.1 Hutchison MediPharma Limited Details
2.12.2 Hutchison MediPharma Limited Major Business
2.12.3 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Product and Solutions
2.12.4 Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Hutchison MediPharma Limited Recent Developments and Future Plans
2.13 ImmunoGen, Inc.
2.13.1 ImmunoGen, Inc. Details
2.13.2 ImmunoGen, Inc. Major Business
2.13.3 ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Product and Solutions
2.13.4 ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 ImmunoGen, Inc. Recent Developments and Future Plans
2.14 Immunomedics, Inc.
2.14.1 Immunomedics, Inc. Details
2.14.2 Immunomedics, Inc. Major Business
2.14.3 Immunomedics, Inc. Mantle Cell Lymphoma Treatment Product and Solutions
2.14.4 Immunomedics, Inc. Mantle Cell Lymphoma Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Immunomedics, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Mantle Cell Lymphoma Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Mantle Cell Lymphoma Treatment Players Market Share in 2021
3.2.2 Top 10 Mantle Cell Lymphoma Treatment Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Mantle Cell Lymphoma Treatment Players Head Office, Products and Services Provided
3.4 Mantle Cell Lymphoma Treatment Mergers & Acquisitions
3.5 Mantle Cell Lymphoma Treatment New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Mantle Cell Lymphoma Treatment Revenue and Market Share by Type (2017-2022)
4.2 Global Mantle Cell Lymphoma Treatment Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Mantle Cell Lymphoma Treatment Revenue Market Share by Application (2017-2022)
5.2 Global Mantle Cell Lymphoma Treatment Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Mantle Cell Lymphoma Treatment Revenue by Type (2017-2028)
6.2 North America Mantle Cell Lymphoma Treatment Revenue by Application (2017-2028)
6.3 North America Mantle Cell Lymphoma Treatment Market Size by Country
6.3.1 North America Mantle Cell Lymphoma Treatment Revenue by Country (2017-2028)
6.3.2 United States Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
6.3.3 Canada Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
6.3.4 Mexico Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Mantle Cell Lymphoma Treatment Revenue by Type (2017-2028)
7.2 Europe Mantle Cell Lymphoma Treatment Revenue by Application (2017-2028)
7.3 Europe Mantle Cell Lymphoma Treatment Market Size by Country
7.3.1 Europe Mantle Cell Lymphoma Treatment Revenue by Country (2017-2028)
7.3.2 Germany Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
7.3.3 France Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
7.3.5 Russia Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
7.3.6 Italy Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Mantle Cell Lymphoma Treatment Revenue by Type (2017-2028)
8.2 Asia-Pacific Mantle Cell Lymphoma Treatment Revenue by Application (2017-2028)
8.3 Asia-Pacific Mantle Cell Lymphoma Treatment Market Size by Region
8.3.1 Asia-Pacific Mantle Cell Lymphoma Treatment Revenue by Region (2017-2028)
8.3.2 China Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
8.3.3 Japan Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
8.3.4 South Korea Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
8.3.5 India Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
8.3.7 Australia Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Mantle Cell Lymphoma Treatment Revenue by Type (2017-2028)
9.2 South America Mantle Cell Lymphoma Treatment Revenue by Application (2017-2028)
9.3 South America Mantle Cell Lymphoma Treatment Market Size by Country
9.3.1 South America Mantle Cell Lymphoma Treatment Revenue by Country (2017-2028)
9.3.2 Brazil Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
9.3.3 Argentina Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Mantle Cell Lymphoma Treatment Revenue by Type (2017-2028)
10.2 Middle East & Africa Mantle Cell Lymphoma Treatment Revenue by Application (2017-2028)
10.3 Middle East & Africa Mantle Cell Lymphoma Treatment Market Size by Country
10.3.1 Middle East & Africa Mantle Cell Lymphoma Treatment Revenue by Country (2017-2028)
10.3.2 Turkey Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
10.3.4 UAE Mantle Cell Lymphoma Treatment Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Mantle Cell Lymphoma Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Mantle Cell Lymphoma Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Mantle Cell Lymphoma Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Mantle Cell Lymphoma Treatment Revenue (USD Million) by Region (2017-2022)
Table 5. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Region (2023-2028)
Table 6. Astex Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Astex Pharmaceuticals, Inc. Major Business
Table 8. Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Product and Solutions
Table 9. Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Bayer AG Corporate Information, Head Office, and Major Competitors
Table 11. Bayer AG Major Business
Table 12. Bayer AG Mantle Cell Lymphoma Treatment Product and Solutions
Table 13. Bayer AG Mantle Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Bristol-Myers Squibb Company Corporate Information, Head Office, and Major Competitors
Table 15. Bristol-Myers Squibb Company Major Business
Table 16. Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Product and Solutions
Table 17. Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Celgene Corporation Corporate Information, Head Office, and Major Competitors
Table 19. Celgene Corporation Major Business
Table 20. Celgene Corporation Mantle Cell Lymphoma Treatment Product and Solutions
Table 21. Celgene Corporation Mantle Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Cellular Biomedicine Group, Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Cellular Biomedicine Group, Inc. Major Business
Table 24. Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Product and Solutions
Table 25. Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Eisai Corporate Information, Head Office, and Major Competitors
Table 27. Eisai Major Business
Table 28. Eisai Mantle Cell Lymphoma Treatment Product and Solutions
Table 29. Eisai Mantle Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. EpiZyme, Inc. Corporate Information, Head Office, and Major Competitors
Table 31. EpiZyme, Inc. Major Business
Table 32. EpiZyme, Inc. Mantle Cell Lymphoma Treatment Product and Solutions
Table 33. EpiZyme, Inc. Mantle Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Fate Therapeutics, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Fate Therapeutics, Inc. Major Business
Table 36. Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Product and Solutions
Table 37. Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Genentech, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Genentech, Inc. Major Business
Table 40. Genentech, Inc. Mantle Cell Lymphoma Treatment Product and Solutions
Table 41. Genentech, Inc. Mantle Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Gilead Sciences, Inc. Corporate Information, Head Office, and Major Competitors
Table 43. Gilead Sciences, Inc. Major Business
Table 44. Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Product and Solutions
Table 45. Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. GlaxoSmithKline Plc Corporate Information, Head Office, and Major Competitors
Table 47. GlaxoSmithKline Plc Major Business
Table 48. GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Product and Solutions
Table 49. GlaxoSmithKline Plc Mantle Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Hutchison MediPharma Limited Corporate Information, Head Office, and Major Competitors
Table 51. Hutchison MediPharma Limited Major Business
Table 52. Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Product and Solutions
Table 53. Hutchison MediPharma Limited Mantle Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. ImmunoGen, Inc. Corporate Information, Head Office, and Major Competitors
Table 55. ImmunoGen, Inc. Major Business
Table 56. ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Product and Solutions
Table 57. ImmunoGen, Inc. Mantle Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Immunomedics, Inc. Corporate Information, Head Office, and Major Competitors
Table 59. Immunomedics, Inc. Major Business
Table 60. Immunomedics, Inc. Mantle Cell Lymphoma Treatment Product and Solutions
Table 61. Immunomedics, Inc. Mantle Cell Lymphoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Mantle Cell Lymphoma Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Mantle Cell Lymphoma Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Mantle Cell Lymphoma Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Mantle Cell Lymphoma Treatment Players Head Office, Products and Services Provided
Table 66. Mantle Cell Lymphoma Treatment Mergers & Acquisitions in the Past Five Years
Table 67. Mantle Cell Lymphoma Treatment New Entrants and Expansion Plans
Table 68. Global Mantle Cell Lymphoma Treatment Revenue (USD Million) by Type (2017-2022)
Table 69. Global Mantle Cell Lymphoma Treatment Revenue Share by Type (2017-2022)
Table 70. Global Mantle Cell Lymphoma Treatment Revenue Forecast by Type (2023-2028)
Table 71. Global Mantle Cell Lymphoma Treatment Revenue by Application (2017-2022)
Table 72. Global Mantle Cell Lymphoma Treatment Revenue Forecast by Application (2023-2028)
Table 73. North America Mantle Cell Lymphoma Treatment Revenue by Type (2017-2022) & (USD Million)
Table 74. North America Mantle Cell Lymphoma Treatment Revenue by Type (2023-2028) & (USD Million)
Table 75. North America Mantle Cell Lymphoma Treatment Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Mantle Cell Lymphoma Treatment Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Mantle Cell Lymphoma Treatment Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Mantle Cell Lymphoma Treatment Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Mantle Cell Lymphoma Treatment Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe Mantle Cell Lymphoma Treatment Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe Mantle Cell Lymphoma Treatment Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Mantle Cell Lymphoma Treatment Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Mantle Cell Lymphoma Treatment Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Mantle Cell Lymphoma Treatment Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Mantle Cell Lymphoma Treatment Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Mantle Cell Lymphoma Treatment Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Mantle Cell Lymphoma Treatment Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Mantle Cell Lymphoma Treatment Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Mantle Cell Lymphoma Treatment Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Mantle Cell Lymphoma Treatment Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Mantle Cell Lymphoma Treatment Revenue by Type (2017-2022) & (USD Million)
Table 92. South America Mantle Cell Lymphoma Treatment Revenue by Type (2023-2028) & (USD Million)
Table 93. South America Mantle Cell Lymphoma Treatment Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Mantle Cell Lymphoma Treatment Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Mantle Cell Lymphoma Treatment Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Mantle Cell Lymphoma Treatment Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Mantle Cell Lymphoma Treatment Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Mantle Cell Lymphoma Treatment Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Mantle Cell Lymphoma Treatment Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Mantle Cell Lymphoma Treatment Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Mantle Cell Lymphoma Treatment Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Mantle Cell Lymphoma Treatment Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Mantle Cell Lymphoma Treatment Picture
Figure 2. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Type in 2021
Figure 3. Acalabrutinib
Figure 4. JCAR-017
Figure 5. JNJ-64052781
Figure 6. Acalisib
Figure 7. IGN-002
Figure 8. IMGN-529
Figure 9. AFM-11
Figure 10. Others
Figure 11. Mantle Cell Lymphoma Treatment Revenue Market Share by Application in 2021
Figure 12. Hospital Picture
Figure 13. Clinic Picture
Figure 14. Others Picture
Figure 15. Global Mantle Cell Lymphoma Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 16. Global Mantle Cell Lymphoma Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Region (2017-2028)
Figure 18. Global Mantle Cell Lymphoma Treatment Revenue Market Share by Region in 2021
Figure 19. North America Mantle Cell Lymphoma Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Europe Mantle Cell Lymphoma Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Asia-Pacific Mantle Cell Lymphoma Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. South America Mantle Cell Lymphoma Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Middle East and Africa Mantle Cell Lymphoma Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. Mantle Cell Lymphoma Treatment Market Drivers
Figure 25. Mantle Cell Lymphoma Treatment Market Restraints
Figure 26. Mantle Cell Lymphoma Treatment Market Trends
Figure 27. Astex Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 28. Bayer AG Recent Developments and Future Plans
Figure 29. Bristol-Myers Squibb Company Recent Developments and Future Plans
Figure 30. Celgene Corporation Recent Developments and Future Plans
Figure 31. Cellular Biomedicine Group, Inc. Recent Developments and Future Plans
Figure 32. Eisai Recent Developments and Future Plans
Figure 33. EpiZyme, Inc. Recent Developments and Future Plans
Figure 34. Fate Therapeutics, Inc. Recent Developments and Future Plans
Figure 35. Genentech, Inc. Recent Developments and Future Plans
Figure 36. Gilead Sciences, Inc. Recent Developments and Future Plans
Figure 37. GlaxoSmithKline Plc Recent Developments and Future Plans
Figure 38. Hutchison MediPharma Limited Recent Developments and Future Plans
Figure 39. ImmunoGen, Inc. Recent Developments and Future Plans
Figure 40. Immunomedics, Inc. Recent Developments and Future Plans
Figure 41. Global Mantle Cell Lymphoma Treatment Revenue Share by Players in 2021
Figure 42. Mantle Cell Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 43. Global Top 3 Players Mantle Cell Lymphoma Treatment Revenue Market Share in 2021
Figure 44. Global Top 10 Players Mantle Cell Lymphoma Treatment Revenue Market Share in 2021
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 46. Global Mantle Cell Lymphoma Treatment Revenue Share by Type in 2021
Figure 47. Global Mantle Cell Lymphoma Treatment Market Share Forecast by Type (2023-2028)
Figure 48. Global Mantle Cell Lymphoma Treatment Revenue Share by Application in 2021
Figure 49. Global Mantle Cell Lymphoma Treatment Market Share Forecast by Application (2023-2028)
Figure 50. North America Mantle Cell Lymphoma Treatment Sales Market Share by Type (2017-2028)
Figure 51. North America Mantle Cell Lymphoma Treatment Sales Market Share by Application (2017-2028)
Figure 52. North America Mantle Cell Lymphoma Treatment Revenue Market Share by Country (2017-2028)
Figure 53. United States Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Canada Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Mexico Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Europe Mantle Cell Lymphoma Treatment Sales Market Share by Type (2017-2028)
Figure 57. Europe Mantle Cell Lymphoma Treatment Sales Market Share by Application (2017-2028)
Figure 58. Europe Mantle Cell Lymphoma Treatment Revenue Market Share by Country (2017-2028)
Figure 59. Germany Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. France Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. United Kingdom Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Russia Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Italy Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Asia-Pacific Mantle Cell Lymphoma Treatment Sales Market Share by Type (2017-2028)
Figure 65. Asia-Pacific Mantle Cell Lymphoma Treatment Sales Market Share by Application (2017-2028)
Figure 66. Asia-Pacific Mantle Cell Lymphoma Treatment Revenue Market Share by Region (2017-2028)
Figure 67. China Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Japan Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South Korea Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. India Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Southeast Asia Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Australia Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. South America Mantle Cell Lymphoma Treatment Sales Market Share by Type (2017-2028)
Figure 74. South America Mantle Cell Lymphoma Treatment Sales Market Share by Application (2017-2028)
Figure 75. South America Mantle Cell Lymphoma Treatment Revenue Market Share by Country (2017-2028)
Figure 76. Brazil Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Argentina Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Middle East and Africa Mantle Cell Lymphoma Treatment Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Mantle Cell Lymphoma Treatment Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Mantle Cell Lymphoma Treatment Revenue Market Share by Country (2017-2028)
Figure 81. Turkey Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Saudi Arabia Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. UAE Mantle Cell Lymphoma Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
